The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Bronchopulmonary Dysplasia: Executive Summary of a Workshop
Open accessAbstract
D espite significant advances in perinatal care, bronchopulmonary dysplasia (BPD) remains one of the most common, complex, and intriguing diseases in perinatal medicine. The pathogenesis of BPD remains to be elucidated fully. Defining this disease continues to be imprecise and varies across institutions, and evidence-based guidelines addressing management are lacking. To address these and other knowledge gaps, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) held a workshop on BPD in October 2016. Information presented at the workshop included an overview of BPD providing a definition, epidemiology, pathogenesis pathways, and the strengths and limitations of available management options. The expert panel also discussed a research agenda; the use of advanced technology including medications, respiratory support measures, modern imaging, and management for preventing and treating BPD; and the current approach to the follow-up of these infants. The workshop panel developed a proposal for an updated definition for BPD based on prior definitions and current care practices. This report provides a summary of the workshop proceedings. BPD was first described in 1967 by Northway et al in an era when the mortality from respiratory distress syndrome (RDS) was >50%. Infants who were ventilated and survived the initial phase of RDS often recovered slowly from their pulmonary injury. Northway et al reported the stages of lung injury progression. The authors named the disorder, BPD, a chronic disease with a “prolonged healing phase” of RDS. Oxygen toxicity, positive pressure ventilation, and endotracheal intubation were all implicated as causative factors for the development of BPD. Later, injuries from mechanical ventilation (“ventilatorinduced lung injury”) captured by the catch phrase— “pressure + volume + time”—was emphasized as causative factors for BPD. Initially, researchers included radiologic features and pathologic findings when available to define BPD. As the survival rate of RDS increased with more BPD survivors, a clinical definition for BPD was adopted as “those infants requiring supplemental oxygen on post-natal day 28.” As more immature infants survived, it was felt that day 28 oxygen use could be related to other factors (eg, prematurity) and in 1988, Shennan et al refined the definition to oxygen use at 36 weeks postmenstrual age (PMA). In 2000, a workshop sponsored by the National Heart, Lung and Blood Institute proposed a more comprehensive definition for BPD to help identify varying severity and, thus, they categorized BPD as “none, mild, moderate or severe.” “No BPD” was defined as <28 days of supplemental oxygen. Mild BPD included infants who received oxygen or respiratory support for >28 days but were on room air at 36 weeks PMA. Infants with moderate BPD required supplemental oxygen, <30% fraction of inspired oxygen concentration, at 36 weeks PMA. Finally, severe BPD was classified as the use of >30% oxygen or positive pressure at 36 weeks PMA. After the National Heart, Lung and Blood Institute workshop, a further refinement in the definition included a physiologic challenge of supplemental oxygen withdrawal to test for oxygen need at 36 weeks PMA. Infants were classified as “Yes BPD” by the “Physiologic definition of BPD” if they had an oxygen saturation of <88% within 60 minutes of a “room air challenge test.” Subsequently, the saturation target was
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
JOBE, A. H., & BANCALARI, E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2011060 · Cited by 4,795
Self-citationNorthway, W. H., Rosan, R. C., & Porter, D. Y. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702162760701 · Cited by 3,013
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
Roberts, D., Brown, J., Medley, N., & Dalziel, S. R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004454.pub3 · Cited by 2,806
Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012
Stoll, B. J., Hansen, N. I., Bell, E. F., Walsh, M. C., Carlo, W. A., Shankaran, S., Laptook, A. R., Sánchez, P. J., Van Meurs, K. P., Wyckoff, M., et al. (2015) · JAMA · doi:10.1001/jama.2015.10244 · Cited by 2,791
Self-citationStoll, B. J., Hansen, N., Fanaroff, A. A., Wright, L. L., Carlo, W. A., Ehrenkranz, R. A., Lemons, J. A., Donovan, E. F., Stark, A. R., Tyson, J. E., et al. (2002) · Pediatrics · doi:10.1542/peds.110.2.285 · Cited by 2,355
Shennan, A. T., Dunn, M. S., Ohlsson, A., Lennox, K., & Hoskins, E. M. (1988) · Pediatrics · doi:10.1542/peds.82.4.527 · Cited by 1,254
Caffeine Therapy for Apnea of Prematurity
Schmidt, B., Roberts, R. S., Davis, P., Doyle, L. W., Barrington, K. J., Ohlsson, A., Solimano, A., & Tin, W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054065 · Cited by 1,208
Early CPAP versus Surfactant in Extremely Preterm Infants
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911783 · Cited by 1,043
Target Ranges of Oxygen Saturation in Extremely Preterm Infants
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911781 · Cited by 961
Long-Term Effects of Caffeine Therapy for Apnea of Prematurity
Schmidt, B., Roberts, R. S., Davis, P., Doyle, L. W., Barrington, K. J., Ohlsson, A., Solimano, A., & Tin, W. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073679 · Cited by 948
The STOP-ROP Multicenter Study Group (2000) · Pediatrics · doi:10.1542/peds.105.2.295 · Cited by 660
Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates
Walsh, M. C., Yao, Q., Gettner, P. A., Hale, E. C., Collins, M. V., Hensman, A. M., Everette, R., Peters, N. J., Miller, N., Muran, G., et al. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0204 · Cited by 641
Flynn, J. T., & Bancalari, E. (2000) · Journal of American Association for Pediatric Ophthalmology and Strabismus · doi:10.1067/mpa.2000.105823 · Cited by 620
Self-citationVitamin A Supplementation for Extremely-Low-Birth-Weight Infants
Tyson, J. E., Wright, L. L., Oh, W., Kennedy, K. A., Mele, L., Ehrenkranz, R. A., Stoll, B. J., Lemons, J. A., Stevenson, D. K., Bauer, C. R., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402505 · Cited by 561
Self-citationOxygen-Saturation Targets and Outcomes in Extremely Preterm Infants
Askie, L. M., Henderson-Smart, D. J., Irwig, L., & Simpson, J. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023080 · Cited by 524
Oxygen Saturation and Outcomes in Preterm Infants
The BOOST II United Kingdom, A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302298 · Cited by 504
Mesenchymal Stem Cells for Bronchopulmonary Dysplasia: Phase 1 Dose-Escalation Clinical Trial
Chang, Y. S., Ahn, S. Y., Yoo, H. S., Sung, S. I., Choi, S. J., Oh, W. I., & Park, W. S. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.12.011 · Cited by 455
Early Pulmonary Vascular Disease in Preterm Infants at Risk for Bronchopulmonary Dysplasia
Mourani, P. M., Sontag, M. K., Younoszai, A., Miller, J. I., Kinsella, J. P., Baker, C. D., Poindexter, B. B., Ingram, D. A., & Abman, S. H. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201409-1594oc · Cited by 450
Postnatal Corticosteroids to Treat or Prevent Chronic Lung Disease in Preterm Infants
Committee on Fetus and Newborn (2002) · Pediatrics · doi:10.1542/peds.109.2.330 · Cited by 442
Safety, Reliability, and Validity of a Physiologic Definition of Bronchopulmonary Dysplasia
Walsh, M. C., Wilson-Costello, D., Zadell, A., Newman, N., & Fanaroff, A. (2003) · Journal of Perinatology · doi:10.1038/sj.jp.7210963 · Cited by 429
Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia
Abman, S. H., Collaco, J. M., Shepherd, E. G., Keszler, M., Cuevas-Guaman, M., Welty, S. E., Truog, W. E., McGrath-Morrow, S. A., Moore, P. E., Rhein, L. M., et al. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.10.082 · Cited by 429
Self-citationEpidemiology of bronchopulmonary dysplasia
Jensen, E. A., & Schmidt, B. (2014) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.23235 · Cited by 419
Schmidt, B., Whyte, R. K., Asztalos, E. V., Moddemann, D., Poets, C., Rabi, Y., Solimano, A., Roberts, R. S., & Canadian Oxygen Trial (COT) Group, F. T. (2013) · JAMA · doi:10.1001/jama.2013.5555 · Cited by 409
Survival Without Disability to Age 5 Years After Neonatal Caffeine Therapy for Apnea of Prematurity
Schmidt, B. (2012) · JAMA · doi:10.1001/jama.2011.2024 · Cited by 403
Variation in Performance of Neonatal Intensive Care Units in the United States
Horbar, J. D., Edwards, E. M., Greenberg, L. T., Morrow, K. A., Soll, R. F., Buus-Frank, M. E., & Buzas, J. S. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2016.4396 · Cited by 385
Controlled Trial of Dexamethasone in Respirator-Dependent Infants with Bronchopulmonary Dysplasia
Avery, G. B., Fletcher, A. B., Kaplan, M., & Brudno, D. S. (1985) · Pediatrics · doi:10.1542/peds.75.1.106 · Cited by 379
O'Shea, T. M., Kothadia, J. M., Klinepeter, K. L., Goldstein, D. J., Jackson, B. G., Weaver, R. G., & Dillard, I. A. R. G. (1999) · Pediatrics · doi:10.1542/peds.104.1.15 · Cited by 376
Carlo, W. A. (2011) · JAMA · doi:10.1001/jama.2011.1752 · Cited by 366
Baud, O., Maury, L., Lebail, F., Ramful, D., El Moussawi, F., Nicaise, C., Zupan-Simunek, V., Coursol, A., Beuchée, A., Bolot, P., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00202-6 · Cited by 364
Isayama, T., Iwami, H., McDonald, S., & Beyene, J. (2016) · JAMA · doi:10.1001/jama.2016.10708 · Cited by 310
Avoiding Endotracheal Ventilation to Prevent Bronchopulmonary Dysplasia: A Meta-analysis
Fischer, H. S., & Bührer, C. (2013) · Pediatrics · doi:10.1542/peds.2013-1880 · Cited by 292
Davis, J. M., Parad, R. B., Michele, T., Allred, E., Price, A., Rosenfeld, W., & for the North American Recombinant Human CuZnSOD Study Group (2003) · Pediatrics · doi:10.1542/peds.111.3.469 · Cited by 268
McEvoy, C. T., & Spindel, E. R. (2017) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2016.08.005 · Cited by 256
Isayama, T., Lee, S. K., Yang, J., Lee, D., Daspal, S., Dunn, M., Shah, P. S., & for the Canadian Neonatal Network and Canadian Neonatal Follow-Up Network Investigators (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2016.4141 · Cited by 230
Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort
Zeitlin, J., El Ayoubi, M., Jarreau, P.-H., Draper, E. S., Blondel, B., Künzel, W., Cuttini, M., Kaminski, M., Gortner, L., Van Reempts, P., et al. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.05.002 · Cited by 223
Schmidt, B., Roberts, R. S., Anderson, P. J., Asztalos, E. V., Costantini, L., Davis, P. G., Dewey, D., D’Ilario, J., Doyle, L. W., Grunau, R. E., et al. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.0238 · Cited by 218
McEvoy, C. T., Schilling, D., Clay, N., Jackson, K., Go, M. D., Spitale, P., Bunten, C., Leiva, M., Gonzales, D., Hollister-Smith, J., et al. (2014) · JAMA · doi:10.1001/jama.2014.5217 · Cited by 217 · cited 1×
“Vitamin C supplementation administered to pregnant women can reduce wheezing at 1 year of age in newborns whose mothers were smokers.(31) Maternal smoking was also identified as a postdischarge factor that was independently associated with later respiratory morbidity in the first year of life.”
BackgroundNeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol
the NeOProM Collaborative Group, Askie, L. M., Brocklehurst, P., Darlow, B. A., Finer, N., Schmidt, B., & Tarnow-Mordi, W. (2011) · BMC Pediatrics · doi:10.1186/1471-2431-11-6 · Cited by 209
Self-citationLate (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants
Halliday, H. L., Ehrenkranz, R. A., & Doyle, L. W. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001145.pub2 · Cited by 205
Ahn, S. Y., Chang, Y. S., Kim, J. H., Sung, S. I., & Park, W. S. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.02.061 · Cited by 202
Keller, R. L., Feng, R., DeMauro, S. B., Ferkol, T., Hardie, W., Rogers, E. E., Stevens, T. P., Voynow, J. A., Bellamy, S. L., Shaw, P. A., et al. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.04.026 · Cited by 199
Self-citationAntenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants
Morrow, L. A., Wagner, B. D., Ingram, D. A., Poindexter, B. B., Schibler, K., Cotten, C. M., Dagle, J., Sontag, M. K., Mourani, P. M., & Abman, S. H. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2414oc · Cited by 194
Neurodevelopmental Outcomes in the Early CPAP and Pulse Oximetry Trial
Vaucher, Y. E., Peralta-Carcelen, M., Finer, N. N., Carlo, W. A., Gantz, M. G., Walsh, M. C., Laptook, A. R., Yoder, B. A., Faix, R. G., Das, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208506 · Cited by 190
Self-citationOxygen Plus Pressure Plus Time: The Etiology of Bronchopulmonary Dysplasia
Philip, A. G. S. (1975) · Pediatrics · doi:10.1542/peds.55.1.44 · Cited by 174
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants
Jefferies, A. L. (2012) · Paediatrics & Child Health · doi:10.1093/pch/17.10.573 · Cited by 173
Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond
Mourani, P. M., & Abman, S. H. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328360a3f6 · Cited by 154
Late Outcomes of a Randomized Trial of High-Frequency Oscillation in Neonates
Zivanovic, S., Peacock, J. L., Alcazar‐Paris, M., Lo, J., Lunt, A. C., Marlow, N., Calvert, S., & Greenough, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309220 · Cited by 133
Walsh, M. C., Laptook, A. R., Kazzi, S. N. J., Engle, W. A., Yao, Q., Rasmussen, M. R., Buchter, S., Heldt, G. P., Rhine, W. D., Higgins, R., et al. (2007) · PEDIATRICS · doi:10.1542/peds.2006-2656 · Cited by 132
Self-citationVitamin A Supplementation for Extremely Low Birth Weight Infants: Outcome at 18 to 22 Months
Ambalavanan, N., Tyson, J. E., Kennedy, K. A., Hansen, N. I., Vohr, B. R., Wright, L. L., & Carlo, W. A. (2005) · PEDIATRICS · doi:10.1542/peds.2004-1812 · Cited by 132
Respiratory Outcomes of the Surfactant Positive Pressure and Oximetry Randomized Trial (SUPPORT)
Stevens, T. P., Finer, N. N., Carlo, W. A., Szilagyi, P. G., Phelps, D. L., Walsh, M. C., Gantz, M. G., Laptook, A. R., Yoder, B. A., Faix, R. G., et al. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.02.054 · Cited by 129
Self-citationO’Reilly, M., Sozo, F., & Harding, R. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12068 · Cited by 105
Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants
Doyle, L. W., Ehrenkranz, R. A., & Halliday, H. L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001145.pub3 · Cited by 100
Stem cell–based therapy for neonatal lung disease: it is in the juice
Fung, M. E., & Thébaud, B. (2013) · Pediatric Research · doi:10.1038/pr.2013.176 · Cited by 97
Maitre, N. L., Ballard, R. A., Ellenberg, J. H., Davis, S. D., Greenberg, J. M., Hamvas, A., Pryhuber, G., & Program, F. T. P. A. R. O. (2015) · Journal of Perinatology · doi:10.1038/jp.2015.19 · Cited by 95
Self-citationWalkup, L. L., Tkach, J. A., Higano, N. S., Thomen, R. P., Fain, S. B., Merhar, S. L., Fleck, R. J., Amin, R. S., & Woods, J. C. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201503-0552oc · Cited by 94
Self-citationHahn, A. D., Higano, N. S., Walkup, L. L., Thomen, R. P., Cao, X., Merhar, S. L., Tkach, J. A., Woods, J. C., & Fain, S. B. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25394 · Cited by 94
Self-citationThe Prematurity and Respiratory Outcomes Program Investigators, Pryhuber, G., Maitre, N. L., Ballard, R. A., Cifelli, D., Davis, S. D., Ellenberg, J. H., Greenberg, J. M., Kemp, J. S., Mariani, T. J., et al. (2015) · BMC Pediatrics · doi:10.1186/s12887-015-0346-3 · Cited by 89
Self-citationKaempf, J. W., Wu, Y., Kaempf, A. J., Kaempf, A. M., Wang, L., & Grunkemeier, G. L. (2011) · Journal of Perinatology · doi:10.1038/jp.2011.102 · Cited by 84
Carlo, W. A., McDonald, S. A., Fanaroff, A. A., Vohr, B. R., Stoll, B. J., Ehrenkranz, R. A., Andrews, W. W., Wallace, D., Das, A., Bell, E. F., et al. (2012) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e31825021ef · Cited by 79
Self-citationThunqvist, P., Gustafsson, P., Norman, M., Wickman, M. C., & Hallberg, J. (2014) · Pediatric Pulmonology · doi:10.1002/ppul.23090 · Cited by 64
Lung function among infants born preterm, with or without bronchopulmonary dysplasia
Sánchez‐Solís, M., García‐Marcos, L., Bosch-Giménez, V. M., Pérez‐Fernández, V., Pastor‐Vivero, M. D., & Mondéjar-López, P. (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21609 · Cited by 54
Respiratory morbidity at follow-up of small-for-gestational-age infants born very prematurely
Peacock, J. L., Lo, J., D’Costa, W., Calvert, S., Marlow, N., & Greenough, A. (2012) · Pediatric Research · doi:10.1038/pr.2012.201 · Cited by 46
Jensen, E. A., Dysart, K., Gantz, M. G., Carper, B. A., Higgins, R. D., Keszler, M., Laughon, M. M., Poindexter, B. B., Stoll, B. J., Walsh, M. C., et al. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.02.003 · Cited by 44
Self-citationCell Therapy for Bronchopulmonary Dysplasia: Promises and Perils
Möbius, M. A., & Thébaud, B. (2016) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2016.06.001 · Cited by 24
Cited by
The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach
Jensen, E. A., Dysart, K., Gantz, M. G., McDonald, S., Bamat, N. A., Keszler, M., Kirpalani, H., Laughon, M. M., Poindexter, B. B., Duncan, A. F., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201812-2348oc · Cited by 1,239
Thébaud, B., Goss, K. N., Laughon, M., Whitsett, J. A., Abman, S. H., Steinhorn, R. H., Aschner, J. L., Davis, P. G., McGrath-Morrow, S. A., Soll, R. F., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0127-7 · Cited by 1,070
Self-citationSoar, J., Berg, K. M., Andersen, L. W., Böttiger, B. W., Cacciola, S., Callaway, C. W., Couper, K., Cronberg, T., D’Arrigo, S., Deakin, C. D., et al. (2020) · Resuscitation · doi:10.1016/j.resuscitation.2020.09.012 · Cited by 616
Wyckoff, M. H., Wyllie, J., Aziz, K., de Almeida, M. F., Fabres, J., Fawke, J., Guinsburg, R., Hosono, S., Isayama, T., Kapadia, V. S., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000895 · Cited by 356
Soar, J., Maconochie, I., Wyckoff, M. H., Olasveengen, T. M., Singletary, E. M., Greif, R., Aickin, R., Bhanji, F., Donnino, M. W., Mancini, M. E., et al. (2019) · Resuscitation · doi:10.1016/j.resuscitation.2019.10.016 · Cited by 345
Metadata
- Authors
- Higgins, R. D., Jobe, A. H., Koso-Thomas, M., Bancalari, E., Viscardi, R. M., Hartert, T. V., Ryan, R. M., Kallapur, S. G., Steinhorn, R. H., Konduri, G. G., Davis, S. D., Thebaud, B., Clyman, R. I., Collaco, J. M., Martin, C. R., Woods, J. C., Finer, N. N., & Raju, T. N. K.
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 197
- Pages
- 300-308
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W2790554076
- Cited by
- 956
- References
- 64
- FWCI
- 48.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.